International Journal of Molecular Sciences (Oct 2022)

Zinc Oxide Nanoparticles Induce Toxicity in H9c2 Rat Cardiomyoblasts

  • Criselda Mendoza-Milla,
  • Fernanda Isabel Macías Macías,
  • Kimberly Abigail Velázquez Delgado,
  • Manuel Alejandro Herrera Rodríguez,
  • Zaira Colín-Val,
  • María del Pilar Ramos-Godinez,
  • Agustina Cano-Martínez,
  • Anita Vega-Miranda,
  • Diana Xochiquetzal Robledo-Cadena,
  • Norma Laura Delgado-Buenrostro,
  • Yolanda Irasema Chirino,
  • José Ocotlán Flores-Flores,
  • Rebeca López-Marure

DOI
https://doi.org/10.3390/ijms232112940
Journal volume & issue
Vol. 23, no. 21
p. 12940

Abstract

Read online

Zinc oxide nanoparticles (ZnO NPs) are widely used in the cosmetic industry. They are nano-optical and nano-electrical devices, and their antimicrobial properties are applied in food packaging and medicine. ZnO NPs penetrate the body through inhalation, oral, and dermal exposure and spread through circulation to various systems and organs. Since the cardiovascular system is one of the most vulnerable systems, in this work, we studied ZnO NPs toxicity in H9c2 rat cardiomyoblasts. Cardiac cells were exposed to different concentrations of ZnO NPs, and then the morphology, proliferation, viability, mitochondrial membrane potential (ΔΨm), redox state, and protein expression were measured. Transmission electron microscopy (TEM) and hematoxylin–eosin (HE) staining showed strong morphological damage. ZnO NPs were not observed inside cells, suggesting that Zn2+ ions were internalized, causing the damage. ZnO NPs strongly inhibited cell proliferation and MTT reduction at 10 and 20 μg/cm2 after 72 h of treatment. ZnO NPs at 20 μg/cm2 elevated DCF fluorescence, indicating alterations in the cellular redox state associated with changes in ΔΨm and cell death. ZnO NPs also reduced the intracellular expression of troponin I and atrial natriuretic peptide. ZnO NPs are toxic for cardiac cells; therefore, consumption of products containing them could cause heart damage and the development of cardiovascular diseases.

Keywords